VOYA Investment Management
TGTX icon

VOYA Investment Management’s TG Therapeutics TGTX Stock Holding History

VOYA Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45M Buy
819,253
+399,644
+95% +$16.4M 0.04% 330
2026
Q1 		$13.9M Buy
419,609
+14,747
+4% +$439K 0.01% 539
2025
Q4 		$12.1M Buy
404,862
+135
+0% +$4.41K 0.01% 606
2025
Q3 		$14.6M Sell
404,727
-18,054
-4% -$595K 0.01% 570
2025
Q2 		$15.2M Buy
422,781
+122,328
+41% +$4.55M 0.02% 612
2025
Q1 		$11.8M Buy
300,453
+26,714
+10% +$899K 0.01% 684
2024
Q4 		$8.24M Buy
273,739
+218,766
+398% +$6.28M 0.01% 803
2024
Q3 		$1.29M Buy
54,973
+8,511
+18% +$186K ﹤0.01% 1507
2024
Q2 		$827K Buy
46,462
+926
+2% +$14.8K ﹤0.01% 1727
2024
Q1 		$693K Sell
45,536
-9,452
-17% -$151K ﹤0.01% 1835
2023
Q4 		$939K Sell
54,988
-173,877
-76% -$2.02M ﹤0.01% 1714
2023
Q3 		$1.91M Buy
228,865
+1,444
+0.6% +$20.1K ﹤0.01% 1342
2023
Q2 		$5.65M Buy
227,421
+175,895
+341% +$4.54M 0.01% 942
2023
Q1 		$775K Sell
51,526
-545
-1% -$8.28K ﹤0.01% 1801
2022
Q4 		$616K Sell
52,071
-25,675
-33% -$186K ﹤0.01% 1906
2022
Q3 		$460K Sell
77,746
-1,046
-1% -$6.86K ﹤0.01% 2074
2022
Q2 		$335K Buy
78,792
+12,898
+20% +$80.5K ﹤0.01% 2100
2022
Q1 		$627K Buy
65,894
+15,753
+31% +$182K ﹤0.01% 1774
2021
Q4 		$953K Sell
50,141
-106,012
-68% -$2.75M ﹤0.01% 1576
2021
Q3 		$5.2M Sell
156,153
-9,734
-6% -$301K 0.01% 828
2021
Q2 		$6.43M Sell
165,887
-6,647
-4% -$261K 0.01% 784
2021
Q1 		$8.31M Sell
172,534
-16,850
-9% -$810K 0.02% 641
2020
Q4 		$9.85M Buy
189,384
+146,408
+341% +$4.95M 0.02% 577
2020
Q3 		$1.15M Buy
42,976
+9,519
+28% +$219K ﹤0.01% 1225
2020
Q2 		$652K Sell
33,457
-9,499
-22% -$153K ﹤0.01% 1487
2020
Q1 		$423K Buy
42,956
+1,166
+3% +$14.7K ﹤0.01% 1724
2019
Q4 		$464K Buy
41,790
+12,597
+43% +$95.8K ﹤0.01% 1924
2019
Q3 		$164K Hold
29,193
– – ﹤0.01% 2297
2019
Q2 		$253K Buy
29,193
+2,674
+10% +$20.2K ﹤0.01% 2164
2019
Q1 		$213K Hold
26,519
– – ﹤0.01% 2242
2018
Q4 		$109K Buy
26,519
+2,948
+13% +$14.7K ﹤0.01% 2382
2018
Q3 		$132K Hold
23,571
– – ﹤0.01% 2449
2018
Q2 		$310K Buy
23,571
+1,050
+5% +$14.4K ﹤0.01% 2127
2018
Q1 		$320K Hold
22,521
– – ﹤0.01% 2068
2017
Q4 		$185K Hold
22,521
– – ﹤0.01% 2369
2017
Q3 		$267K Hold
22,521
– – ﹤0.01% 2232
2017
Q2 		$226K Buy
22,521
+6,463
+40% +$72.3K ﹤0.01% 2345
2017
Q1 		$187K Buy
16,058
+1,188
+8% +$8.53K ﹤0.01% 2295
2016
Q4 		$69K Hold
14,870
– – ﹤0.01% 2488
2016
Q3 		$115K Hold
14,870
– – ﹤0.01% 2447
2016
Q2 		$90K Hold
14,870
– – ﹤0.01% 2486
2016
Q1 		$127K Hold
14,870
– – ﹤0.01% 2350
2015
Q4 		$177K Hold
14,870
– – ﹤0.01% 2331
2015
Q3 		$150K Sell
14,870
-4,682
-24% -$69.8K ﹤0.01% 2379
2015
Q2 		$324K Hold
19,552
– – ﹤0.01% 2211
2015
Q1 		$303K Hold
19,552
– – ﹤0.01% 2220
2014
Q4 		$310K Hold
19,552
– – ﹤0.01% 2242
2014
Q3 		$209K Hold
19,552
– – ﹤0.01% 2469
2014
Q2 		$184K Buy
+19,552
New +$125K ﹤0.01% 2585

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

VOYA Investment Management's TGTX Position: Q2 2026 in Review

VOYA Investment Management increased its TG Therapeutics (TGTX) stake by 95% in Q2 2026, buying an estimated $16.4M and bringing the position to 819,253 shares worth $45M. The position accounts for 0.04% of the portfolio, ranked #330.

VOYA Investment Management first reported a position in TGTX in Q2 2014 and has held it in 49 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • VOYA Investment Management held 819,253 shares of TG Therapeutics worth $45M as of Q2 2026.
  • VOYA Investment Management bought 399,644 TG Therapeutics shares in Q2 2026, an estimated $16.4M.
  • TG Therapeutics made up 0.04% of VOYA Investment Management's portfolio in Q2 2026, its #330 holding.
  • VOYA Investment Management first reported a position in TG Therapeutics in Q2 2014 and has held it in 49 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.